# OnCo record scalop (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/scalop/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "scalop", "NCT01032057" ;
  schema:name "SCALOP"@en ;
  schema:alternateName "SCALOP-1"@en, "Selective Chemoradiation in Advanced Localised Pancreatic cancer"@en ;
  schema:description "SCALOP is the UK trial that decided which chemotherapy to give with radiotherapy for pancreatic cancer that cannot be removed: after three months of induction chemotherapy, capecitabine during radiotherapy gave longer survival and far less blood toxicity than gemcitabine, and it is the radiosensitiser NICE recommends."@en ;
  schema:url <https://onco.cc/trials/scalop/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01032057>, <https://doi.org/10.1016/S1470-2045(13)70021-4>, <https://doi.org/10.1038/bjc.2017.95>, <https://www.isrctn.com/ISRCTN96169987> ;
  onco:status "positive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/locally-advanced-pdac/> ;
  onco:technologies <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:institutions <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/ca19-9/> ;
  onco:people <https://onco.cc/people/david-cunningham/> .